Company / CapEx per Share
Krystal Biotech, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.42
FY2025
5-year range
$0.15 / $3.08
FY2021-FY2025
Trend
+176.5%
vs FY2024
Sector context
#32 of 192
Health Care
What the data says
Krystal Biotech, Inc.'s capex per share of $0.42 is higher than 83% of companies in the Health Care sector (FY2025). CapEx per Share returned to growth in FY2025 after 3 years of decline, reaching $0.42.
Based on SEC 10-K filings.
0.42 in FY2025 with a 5-year CAGR of -12.1%. Top quartile in the Health Care sector.
Declined from $0.46 to $0.42 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -41.5%
- 5-Year CAGR
- -12.1%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 192This company $0.42 Sector average $3.54
▼
-88.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 176.5% year-over-year.
- Ranks #32 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.42 | +176.5% |
| FY2024 | $0.15 | -67.2% |
| FY2023 | $0.46 | -78.0% |
| FY2022 | $2.08 | -32.5% |
| FY2021 | $3.08 | +289.7% |
| FY2020 | $0.79 | +96.3% |
| FY2019 | $0.40 | +101.8% |
| FY2018 | $0.20 | +409.0% |
| FY2017 | $0.04 | +129.2% |
| FY2016 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026